Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors

被引：0
|
作者：
Igawa, Yukiko Shimoda
Yoshida, Tatsuya
Yoshinami, Yuri
Hibino, Yukiko
Arima, Takamichi
Sato, Jun
Maruki, Yuta
Shoji, Hirokazu
Namikawa, Kenjiro
Sudo, Kazuki
Honma, Yoshitaka
Hashimoto, Hironobu
Yamazaki, Naoya
Okusaka, Takuji
Yonemori, Kan
Yamamoto, Noboru
Ohe, Yuichiro
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
[3] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Dept Pharm, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[7] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[8] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12133
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [42] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [43] Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.
    Grizzi, Giulia
    Petrelli, Fausto
    Ghidini, Michele
    Ghidini, Antonio
    Ratti, Margherita
    Panni, Stefano
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Parati, Maria Chiara
    Barni, Sandro
    Tomasello, Gianluca
    Passalacqua, Rodolfo
    Berruti, Alfredo
    Brighenti, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series
    Tew, Alice
    Khoja, Leila
    Pallan, Lalit
    Steven, Neil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1163 - 1171
  • [45] Incidence of immune-related adverse events in US veterans treated with immune checkpoint inhibitors
    Krall, Courtney
    Tague, Marshall
    Lund, Brian C.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (08) : 1372 - 1377
  • [46] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511
  • [47] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [48] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [49] Development of a novel immune-related toxicity grading system for predicting outcomes in patients with solid tumours treated with immune checkpoint inhibitors (ICI)
    Kapiris, Matthaios
    Santaolalla, Aida
    Bratsos, Sosipatros
    Ghunam, Sundeep
    McDonald, Louisa
    Muhith, Moe
    Wu, Yin
    Georgiou, Alexandros
    Josephs, Debra Hannah
    Sarker, Debashis
    Cope, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors
    Suijkerbuijk, Karijn P. M.
    Kapiteijn, Ellen
    Verheijden, Rik J.
    JAMA ONCOLOGY, 2020, 6 (08) : 1300 - +
12345